National Cancer Institute
Investments by market, targeted sectors and preferred funding rounds
Investments by industry
biotech - 50%
healthtech - 50%
Number of investments: 2
National Cancer Institute invested in Elicio Therapeutics during a round worth $73,000,000 - 2/17/2021
National Cancer Institute invested in Outcomes4Me during a round worth $4,700,000 - 11/18/2020